FDA In Brief > FDA In Brief: FDA advances policies related to bolstering security of drug products in the U.S. supply chain

FDA issues drug supply chain guidances to alert industry of changes to pharmaceutical product identification and tracing procedures.
— Read on www.fda.gov/NewsEvents/Newsroom/FDAInBrief/ucm621095.htm

Today, the FDA is finalizing two guidance documents and making available one draft guidance to help ensure that prescription drug products are identified and traced properly as they move through the supply chain in compliance with federal law.